GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVO) » Definitions » ROE % Adjusted to Book Value

Alvotech (Alvotech) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech ROE % Adjusted to Book Value?

Alvotech's ROE % for the quarter that ended in Dec. 2023 was 0.00%. Alvotech's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Alvotech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.


Alvotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Alvotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech ROE % Adjusted to Book Value Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - - -

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - Negative Equity - -

Competitive Comparison of Alvotech's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Alvotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alvotech's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alvotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alvotech's ROE % Adjusted to Book Value falls into.



Alvotech ROE % Adjusted to Book Value Calculation

Alvotech's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Alvotech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alvotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alvotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alvotech (Alvotech) Business Description

Industry
Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.